About 6 results found for searched term "76-03-9" (0.126 seconds)
| Cat.No. | Name | Target |
|---|---|---|
| M13343 | Trichloroacetic acid | Metabolite/Endogenous Metabolite |
| Trichloroacetic acid (TCA) is derived from trichloroethylene (TCE) metabolism. It can be used as an acid decalcifier. Trichloroacetic acid, a metabolite of Trichloroacetic acid, is believed to contribute to its liver cancer effect in mice. | ||
| M21720 | ZSET1446 (ST101) | AChR/AChE |
| ST101; ZSET-1446 | ||
| ZSET1446 (ST101) is a novel cognitive enhancer that activates T-type voltage-gated calcium channels (VGCCs), and it significantly improves learning deficits in various types of Alzheimer disease (AD) models. | ||
| M24700 | Nemolizumab | IL Receptor/Related |
| CIM331 | ||
| Nemolizumab (CIM331) is a humanized antihuman interleukin-31 receptor A monoclonal antibody that inhibits the binding of interleukin-31 (IL-31) to its receptor and subsequent signal transduction. Nemolizumab can used be in research of atopic dermatitis (AD). | ||
| M41244 | Fosalvudine tidoxil | Reverse Transcriptase |
| Fosalvudine tidoxil is an orally active nucleoside reverse transcriptase inhibitor (NRTI). | ||
| M27999 | TASP0376377 | Prostaglandin Receptor |
| TASP0376377 is a potent and selective CRTH2 antagonist (IC50: 13 nM). TASP0376377 has binding affinity for CRTH2 (IC50: 19 nM). | ||
| M29932 | AZ10397767 | CXCR |
| AZ10397767 is an orally active, selective CXCR2 receptor antagonist with an IC50 of 1 nM. AZ10397767 attenuates the Oxaliplatin-induced NF-κB transcriptional activity and potentiates Oxaliplatin-induced apoptosis in androgen-independent prostate cancer (AIPC) cells. AZ10397767 significantly inhibits neutrophil recruitment into tumors which then adversely affects tumor growth in vitro and in vivo. | ||
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2023 AbMole BioScience. All Rights Reserved.
